Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
‘Next wave of IPOs’ will arrive in summer, predicts VC partner
Medicxi co-founder Francesco De Rubertis pointed to the current popularity of secondary stock offerings as a sign that “investors are excited.”
James Waldron
May 3, 2024 10:49am
CG sets new bar in bladder cancer, months after huge IPO
May 3, 2024 11:23am
Fierce Biotech Layoff Tracker '24: Gilead, Chroma & more
May 3, 2024 3:00pm
QuidelOrtho taps retired Abbott diagnostics leader for CEO
May 3, 2024 2:20pm
Infectious disease DNA tester Karius nets $100M
May 3, 2024 12:18pm
BridgeBio, Ipsen, George Medicines and more—Chutes & Ladders
May 3, 2024 8:30am
Medtech News
New breast cancer guidelines call for first mammogram at age 40
May 2, 2024 3:15pm
Medline sews up Ecolab's surgical drape business for $950M
May 2, 2024 12:26pm
Hologic picks up breast cancer marker maker Endomag for $310M
May 1, 2024 12:00pm
Quest Diagnostics carves out PathAI's digital pathology lab
May 1, 2024 10:30am
See More Medtech News